Cure51 Revenue

Biotechnology Research • Paris, Île-de-France, France • 51-100 Employees

Cure51 revenue & valuation

Annual revenue	$4,363,305
Revenue per employee	$86,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$14,000,000
Total funding	$16,300,000

Key Contacts at Cure51

Nicolas Wolikow

Chief Executive Officer And Founder

Simon Istolainen

Founder

El Mehdi Ouzgane

Cofounder & Coo Chief Operating Officer

Anne Lecadieu

Head Of Sales & Partnerships

Alexandre Syrota

Co-Founder

Marine Odv

Head Of Product

Chloé Monvoisin

Product Owner Intern

Company overview

Headquarters	Paris, Île-de-France, France
Website	cure51.com
NAICS	541714
Founded	2021
Employees	51-100
Socials

Cure51 Email Formats

Cure51 uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@cure51.com), used 42.9% of the time.

Format	Example	Percentage
{first name}.{last name}	john.doe@cure51.com	42.9%
{first initial}.{last name}	j.doe@cure51.com	33.3%
{first initial}	j@cure51.com	19%
{first name}	john@cure51.com	4.8%

About Cure51

Cure 51 is a TechBio aiming at creating the first ever worldwide database of Cancer Survivors. The company was co-created with leading oncology centres and has already identified more than 1500 survivors in 42 countries across all continents. The company has developed its own data collection and discovery platform as well as a dedicated Central Lab to proceed to a multiomic sequencing of the survivors’ samples. Through this approach, Cure51 will identify robust therapeutic targets, validated by its scientific community, in order to develop novel drugs to cure Cancer. The focus for Cure51 is initially to start with 3 types of particularly agressive cancers and will naturally expand to other indications and therapeutic areas to capitalize on its exclusive and unprecedented set of data and discovery pipelines.

Employees by Management Level

Total employees: 51-100

Seniority

Employees

Entry

Manager

Head

Employees by Department

Cure51 has 36 employees across 14 departments.

Departments

Number of employees

Funding Data

Explore Cure51's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount	Link to Article
2024-04-19	3	$16,300,000

Funding Insights

$16,300,000

Total funding amount

$16,300,000

Most recent funding amount

Number of funding rounds

Cure51 Tech Stack

Discover the technologies and tools that power Cure51's digital infrastructure, from frameworks to analytics platforms.

Cloudflare

CDN

Google Workspace

Next.js

JavaScript frameworks

Google Tag Manager

Tag managers

GraphQL

Programming languages

Node.js

Programming languages

Nginx

Reverse proxies

Apollo

JavaScript libraries

React

JavaScript frameworks

Matomo Tag Manager

Tag managers

Matomo Analytics

Analytics

Webpack

Miscellaneous

Frequently asked questions

Cure51 is located in Paris, Île-de-France, FR.

Cure51 generates an estimated annual revenue of $4,363,305. This revenue figure reflects the company's market position and business performance in its industry.

Cure51 has an estimated valuation of $14,000,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Cure51 was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Cure51 has approximately 51-100 employees. The company continues to grow its workforce to support its business operations and expansion.

Cure51 has raised a total of $16,300,000 across 1 funding rounds. This investment has helped the company grow and expand its operations.